| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.4 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.4 |